Toshitaka Nabeshima
Okazaki, 4701192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 203 publications
α6GABAA receptors as novel targets for ADHD therapy: A proof-of-concept study in MK-801-treated juvenile mice.
Journal: European journal of pharmacology
Published: May 05, 2026
Soy lysolecithin attenuates hypertension and behavioral impairments in mice fed a high-salt diet through receptor-specific regulation of prostaglandin signaling and arachidonic acid-derived prostaglandin production.
Journal: Neurochemistry international
Published: March 05, 2026
Corrigendum to "Cortical excitatory and inhibitory neuron deficits may underlie the cognitive and social impairments in a mouse model of schizophrenia with exonic Reln deletion" [Europ. J. Pharmacol. 1010 (2026) 178407].
Journal: European journal of pharmacology
Published: December 23, 2025
Phosphoproteomics identifies Rho-kinase-associated phospho-signaling and autophagy-associated alterations in the medial prefrontal cortex of a schizophrenia-related mouse model.
Journal: Pharmacological research
Published: December 19, 2025
Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis.
Journal: Neurochemistry international
Published: November 25, 2025
Critical interplay between PAF receptor and PKCδ is involved in dopaminergic insult evoked by methamphetamine in mice.
Journal: Chemico-biological interactions
Published: September 18, 2025
Far-infrared radiation-mediated GPx-1/eNOS/ERK signaling contributes to the protective potential against methamphetamine-caused impairments in recognition memory in mice.
Journal: Free radical research
Published: August 20, 2025
Acute systemic immune challenge induces cognitive impairments and anhedonia through interferon-induced transmembrane protein 3 in adult male mice.
Journal: Behavioural brain research
Published: July 31, 2025
Targeting the noradrenergic-metabolic axis: A new strategy for sugar-induced depression subtypes.
Journal: British journal of pharmacology
Published: July 29, 2025
Cortical excitatory and inhibitory neuron deficits may underlie the cognitive and social impairments in a mouse model of schizophrenia with exonic Reln deletion.
Journal: European journal of pharmacology
Published: June 25, 2025
Twinfilin-1 phosphorylation in reelin signaling regulates actin dynamics and spine development.
Journal: Pharmacological research
Published: June 10, 2025
Last Updated: 09/26/2026